635.00
+15.00
+(2.42%)
At close: January 31 at 3:46:36 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
4,542,458.00
3,134,261.00
2,850,274.00
2,279,407.00
Total Liabilities Net Minority Interest
444,951.00
320,562.00
316,050.00
605,356.00
Total Equity Gross Minority Interest
4,097,507.00
2,813,699.00
2,534,224.00
1,674,051.00
Total Capitalization
4,097,507.00
2,813,699.00
2,534,224.00
1,674,051.00
Common Stock Equity
4,097,507.00
2,813,699.00
2,534,224.00
1,674,051.00
Capital Lease Obligations
20,000.00
12,426.00
11,465.00
9,657.00
Net Tangible Assets
3,972,279.00
2,638,798.00
2,362,540.00
1,506,707.00
Working Capital
3,700,744.00
2,471,920.00
2,241,732.00
1,728,508.00
Invested Capital
4,097,507.00
2,813,699.00
2,534,224.00
1,674,051.00
Tangible Book Value
3,972,279.00
2,638,798.00
2,362,540.00
1,506,707.00
Total Debt
20,000.00
12,426.00
11,465.00
9,657.00
Share Issued
59,194.49
55,395.86
51,668.32
47,571.28
Ordinary Shares Number
59,194.49
55,395.86
51,668.32
47,571.28
12/31/2020 - 5/27/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
UNC.SG UCB SA
188.70
-0.21%
UNC.F UCB SA
189.10
-0.29%
UNC.MU UCB SA
188.20
-0.74%
UCBJY UCB SA
97.18
-0.85%
UCB.VI UCB SA
188.60
-0.79%
UCB.BR UCB SA
188.20
-0.61%
CORT Corcept Therapeutics Incorporated
66.92
-4.26%
PPCB Propanc Biopharma, Inc.
10.00
0.00%
AKRO Akero Therapeutics, Inc.
54.08
-2.31%